Webindia 1231mon
LTS completes its entry into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business
Sorrel's large volume wearable injector technologies will enable LTS to go beyond its current passive technology offerings. It opens new opportunities for LTS to support pharma partners in the ...
Hosted on MSN11mon
LTS wins $1.2m grant to develop mRNA therapy patches
In June, LTS acquired Sorrel’s wearable injection device business. The acquisition added a large molecule drug delivery platform to LTS’s portfolio of drug delivery systems. Another company ...